Clinical Trial Update: Hypofractionated LocoRegional Radiotherapy in Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial status update indicates hypofractionated loco-regional radiotherapy for breast cancer is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lymphedema

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Breast Neoplasms, Radiotherapy | Phase 3 | Status: ACTIVE_NOT_RECRUITING